Ikena Oncology, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC | 05/14/2025 | 5.02 M | $6.42 M | 0.00% | 10.40% |
BLUE OWL CAPITAL HOLDINGS LP | 05/15/2025 | 4.09 M | $5.24 M | 0.00% | 8.48% |
BVF INC/IL | 05/15/2025 | 4.01 M | $5.13 M | 0.00% | 8.30% |
BML CAPITAL MANAGEMENT, LLC | 05/07/2025 | 3.71 M | $4.75 M | 3.48% | 7.69% |
ORBIMED ADVISORS LLC | 05/15/2025 | 3.54 M | $4.53 M | 0.00% | 7.33% |
DEEP TRACK CAPITAL, LP | 05/15/2025 | 2.52 M | $3.22 M | 100.00% | 5.21% |
OMEGA FUND MANAGEMENT, LLC | 05/15/2025 | 2.25 M | $2.88 M | 0.00% | 4.66% |
VANGUARD GROUP INC | 05/09/2025 | 1.38 M | $1.77 M | -0.09% | 2.87% |
GILEAD SCIENCES, INC. | 05/13/2025 | 1.16 M | $1.48 M | -42.28% | 2.40% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2025 | 800.00 K | $1.02 M | 0.00% | 1.66% |
NEA MANAGEMENT COMPANY, LLC | 05/14/2025 | 600.06 K | $768.08 K | 0.00% | 1.24% |
SOFINNOVA INVESTMENTS, INC. | 05/15/2025 | 382.62 K | $489.75 K | 0.00% | 0.79% |
BLACKROCK, INC. | 05/02/2025 | 348.63 K | $446.25 K | -0.99% | 0.72% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 317.09 K | $405.97 K | -3.31% | 0.66% |
04/30/2025 | 296.44 K | $379.44 K | -41.63% | 0.61% | |
RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 294.49 K | $376.94 K | -10.82% | 0.61% |
ALDEBARAN CAPITAL, LLC | 05/13/2025 | 247.80 K | $317.18 K | 100.00% | 0.51% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 05/15/2025 | 245.49 K | $314.22 K | -25.02% | 0.51% |
ACADIAN ASSET MANAGEMENT LLC | 05/21/2025 | 209.57 K | $266.00 K | -27.33% | 0.43% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 05/15/2025 | 153.30 K | $196.22 K | -0.33% | 0.32% |
TWO SIGMA ADVISERS, LP | 05/15/2025 | 151.40 K | $193.79 K | -3.81% | 0.31% |
UBS GROUP AG | 05/13/2025 | 100.66 K | $128.85 K | 40.09% | 0.21% |
STATE STREET CORP | 05/15/2025 | 92.15 K | $117.96 K | 0.00% | 0.19% |
DEUTERIUM CAPITAL MANAGEMENT, LLC | 05/08/2025 | 80.58 K | $103.14 K | 0.00% | 0.17% |
CITADEL ADVISORS LLC | 05/15/2025 | 79.69 K | $102.00 K | -0.85% | 0.17% |
TWO SIGMA INVESTMENTS, LP | 05/15/2025 | 79.42 K | $101.66 K | -21.19% | 0.16% |
SQUAREPOINT OPS LLC | 05/15/2025 | 77.43 K | $99.12 K | 77.44% | 0.16% |
GOLDMAN SACHS GROUP INC | 06/27/2025 | 76.46 K | $97.87 K | 62.36% | 0.16% |
BBR PARTNERS, LLC | 05/14/2025 | 70.00 K | $89.60 K | 0.00% | 0.15% |
MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 69.68 K | $89.20 K | -65.10% | 0.14% |
BARCLAYS PLC | 05/15/2025 | 66.18 K | $85.00 K | -66.12% | 0.14% |
NORTHERN TRUST CORP | 05/13/2025 | 57.57 K | $73.68 K | 0.00% | 0.12% |
XTX TOPCO LTD | 05/08/2025 | 56.45 K | $72.26 K | 350.61% | 0.12% |
DIMENSIONAL FUND ADVISORS LP | 05/13/2025 | 38.62 K | $49.55 K | 0.00% | 0.08% |
PRUDENTIAL FINANCIAL INC | 05/13/2025 | 26.00 K | $33.28 K | 42.86% | 0.05% |
BERKSHIRE ASSET MANAGEMENT LLC/PA | 05/14/2025 | 20.00 K | $21.60 K | 0.00% | 0.04% |
VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | 05/14/2025 | 16.95 K | $21.70 K | 3.56% | 0.04% |
MORGAN STANLEY | 05/15/2025 | 12.57 K | $16.09 K | -18.39% | 0.03% |
FMR LLC | 05/12/2025 | 5.06 K | $6.48 K | -52.18% | 0.01% |
JPMORGAN CHASE & CO | 05/12/2025 | 849 | $1.09 K | -99.45% | 0.00% |
COLDSTREAM CAPITAL MANAGEMENT INC | 05/13/2025 | 525 | $672 | 100.00% | 0.00% |
BNP PARIBAS ARBITRAGE, SNC | 05/14/2025 | 315 | $403 | -99.28% | 0.00% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 221 | $283 | -11.95% | 0.00% |
FARTHER FINANCE ADVISORS, LLC | 04/14/2025 | 108 | $135 | 0.00% | 0.00% |
NISA INVESTMENT ADVISORS, LLC | 04/30/2025 | 69 | $88 | -30.30% | 0.00% |
05/02/2025 | 3 | $4 | 0.00% | 0.00% | |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 0 | $0 | -100.00% | 0.00% |
MARQUETTE ASSET MANAGEMENT, LLC | 04/09/2025 | 0 | $0 | -100.00% | 0.00% |
JBF CAPITAL, INC. | 05/08/2025 | 0 | $0 | -100.00% | 0.00% |
TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
Ikena Oncology, Inc. institutional Ownership - FAQ's
During the previous two years, 62 institutional investors and hedge funds held shares of Ikena Oncology, Inc.. The most heavily invested institutionals were:
Atlas Venture Life Science Advisors, LLC: 5.02 M
Blue Owl Capital Holdings LP: 4.09 M
BVF INC/IL: 4.01 M
BML Capital Management, LLC: 3.71 M
ORBIMED ADVISORS LLC: 3.54 M
Deep Track Capital, LP: 2.52 M
67.86% of Ikena Oncology, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 35.02 M shares in the last 24 months. This purchase volume represents approximately $46.58 M in transactions.